Log in to save to my catalogue

Management of antithrombotic therapy during cardiac implantable device surgery

Management of antithrombotic therapy during cardiac implantable device surgery

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f65f47d7f044b32ba9488814a774ec7

Management of antithrombotic therapy during cardiac implantable device surgery

About this item

Full title

Management of antithrombotic therapy during cardiac implantable device surgery

Publisher

Japan: John Wiley & Sons, Inc

Journal title

Journal of arrhythmia, 2016-06, Vol.32 (3), p.163-169

Language

English

Formats

Publication information

Publisher

Japan: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Abstract Anticoagulants are commonly used drugs that are frequently encountered during device placement. Deciding when to halt or continue the use of anticoagulants is a balance between the risks of thromboembolism versus bleeding. Patients taking warfarin with a high risk of thromboembolism should continue to take their warfarin without interrupti...

Alternative Titles

Full title

Management of antithrombotic therapy during cardiac implantable device surgery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5f65f47d7f044b32ba9488814a774ec7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f65f47d7f044b32ba9488814a774ec7

Other Identifiers

ISSN

1880-4276

E-ISSN

1883-2148

DOI

10.1016/j.joa.2015.12.003

How to access this item